Skip Navigation

Emergent BioSolutions CEO on making Narcan affordable and accessible

Mad Money with Jim Cramer

Emergent BioSolutions CEO on making Narcan affordable and accessible

Jim Cramer chats with Emergent BioSolutions CEO Robert Kramer Sr. about the pharmaceutical company's approach to drug pricing.

07:37

Tue, Jun 4 20197:04 PM EDT

Earnings will make new record highs over the next few quarters, says Ed Yardeni

Earnings will make new record highs over the next few quarters, says Ed Yardeni

Charles Schwab's Kevin Gordon: More weakness in the labor market needs to happen for a Fed cut

Charles Schwab's Kevin Gordon: More weakness in the labor market needs to happen for a Fed cut

Google's fate hinges on this man: Demis Hassabis

Google's fate hinges on this man: Demis Hassabis

Austin Ekeler on joining the Washington Commanders

Austin Ekeler on joining the Washington Commanders

The Fed on rate cut timeline, restrictive monetary policy and inflation target

The Fed on rate cut timeline, restrictive monetary policy and inflation target

Earnings will make new record highs over the next few quarters, says Ed Yardeni

Earnings will make new record highs over the next few quarters, says Ed Yardeni

Charles Schwab's Kevin Gordon: More weakness in the labor market needs to happen for a Fed cut

Charles Schwab's Kevin Gordon: More weakness in the labor market needs to happen for a Fed cut

Google's fate hinges on this man: Demis Hassabis

Google's fate hinges on this man: Demis Hassabis

Austin Ekeler on joining the Washington Commanders

Austin Ekeler on joining the Washington Commanders

The Fed on rate cut timeline, restrictive monetary policy and inflation target

The Fed on rate cut timeline, restrictive monetary policy and inflation target